Abstract
Clinical applications of acetylcholinesterase (AChE) inhibitors are widespread in Alzheimer's sufferers in order to activate central cholinergic system and alleviate cognitive deficits by inhibiting the hydrolysis of acetylcholine. In this study, six kinds of chitooligosaccharides (COSs) with different molecular weight and degree of deacetylation were examined for their inhibitory effects against AChE. The 90-COSs exhibited potent AChE inhibitory activities compared to 50-COSs, while 90-MMWCOS (1000-5000 Da) in the 90-COSs showed the highest activity. Cell culture experiment revealed that 90-MMWCOS suppressed the level of AChE protein expression and AChE activity induced by Abeta(25-35) in PC12 cell lines.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcholinesterase / metabolism
-
Alzheimer Disease / metabolism
-
Alzheimer Disease / pathology
-
Amyloid beta-Peptides / chemistry*
-
Animals
-
Brain / metabolism
-
Cell Line
-
Chemistry, Pharmaceutical / methods*
-
Cholinesterase Inhibitors / chemistry
-
Cholinesterase Inhibitors / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Design
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Inhibitory Concentration 50
-
Oligosaccharides / chemistry*
-
PC12 Cells
-
Peptide Fragments / chemistry*
-
Rats
Substances
-
Amyloid beta-Peptides
-
Cholinesterase Inhibitors
-
Enzyme Inhibitors
-
Oligosaccharides
-
Peptide Fragments
-
amyloid beta-protein (25-35)
-
Acetylcholinesterase